Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#99 / 99 Total
ANTX - AN2 Therapeutics Inc - Stock Price Chart
CompanyAN2 Therapeutics Inc
Market Cap62.34MEPS (ttm)-2.59
P/E-EPS this Y10.80%
Forward P/E-EPS next Y-12.44%
PEG-EPS past 5Y-73.03%
P/S-EPS next 5Y-
P/B0.56EPS Q/Q29.36%
Dividend-Sales Q/Q-
Insider Own32.83%Inst Own52.99%
Insider Trans-3.14%Inst Trans0.77%
Short Float3.73%EarningsMay 14/a
Analyst Recom2.20Target Price4.33
Avg Volume234.32K52W Range1.91 - 22.22
AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zakrzewski Joseph SDirectorJan 18 '24Sale19.11100,0001,911,410405,880Jan 19 07:32 PM
Aziz KabeerDirectorJan 16 '24Sale19.65100,0001,965,000377,542Jan 18 06:19 PM
Adjuvant Global Health Technol10% OwnerJan 16 '24Sale19.6584,0931,652,4271,995,958Jan 18 06:18 PM
Adjuvant Global Health Technol10% OwnerJan 16 '24Sale19.6515,907312,573377,542Jan 18 06:18 PM
Readnour Robin ShaneDirectorJan 12 '24Sale21.911,42531,229414,788Jan 17 05:03 PM